014491771	014491771	CD	B-NP	O
|	|	NN	I-NP	O
GLHMC	GLHMC	NN	I-NP	O
|	|	NN	I-NP	O
48970452	48970452	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
477234	477234	CD	B-NP	O
|	|	CC	I-NP	O
8/18/1997	8/18/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
FAMILIAL	FAMILIAL	NNP	I-NP	I-protein
CARDIOMYOPATHY	CARDIOMYOPATHY	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/12/1997	4/12/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/26/1997	7/26/1997	CD	B-NP	O
SERVICE	SERVICE	NN	I-NP	O
:	:	:	O	O
Walk	Walk	NNP	B-NP	O
Verlsa	Verlsa	NNP	I-NP	O
Tempeh	Tempeh	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
SIGNIFICANT	SIGNIFICANT	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
month	month	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
decrease	decrease	NN	B-NP	O
in	in	IN	B-PP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
week	week	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
indigestion	indigestion	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Vergara	Vergara	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
29	29	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
familial	familial	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
1987	1987	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
PCWP	PCWP	NN	I-NP	B-DNA
13	13	CD	I-NP	I-DNA
,	,	,	O	O
CI	CI	NN	B-NP	B-protein
3.8	3.8	CD	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
or	or	CC	O	O
valvular	valvular	JJ	B-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
moderately	moderately	RB	I-NP	O
enlarged	enlarge	VBN	I-NP	O
diffusely	diffusely	RB	I-NP	O
hypokinetic	hypokinetic	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
31	31	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
RA	RA	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
PA	PA	NN	B-NP	O
27/12	27/12	CD	I-NP	O
,	,	,	O	O
SVR	SVR	NN	B-NP	O
779	779	CD	I-NP	O
.	.	.	O	O

Approximately	Approximately	RB	B-NP	O
four	four	CD	I-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
having	have	VBG	I-VP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Vasotec	Vasotec	NNP	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
dilation	dilation	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
heart	heart	NN	I-NP	O
chambers	chamber	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
4.2	4.2	CD	B-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
TR	TR	NN	I-NP	B-protein
and	and	CC	I-NP	I-protein
3	3	CD	I-NP	I-protein
+	+	SYM	I-NP	O
MR.	MR.	NN	I-NP	O
ETT	ETT	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
1994	1994	CD	I-NP	O
was	be	VBD	B-VP	O
9	9	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
seconds	second	NNS	I-NP	O
in	in	IN	B-PP	O
duration	duration	NN	B-NP	O
revealing	reveal	VBG	B-VP	O
only	only	RB	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
,	,	,	O	O
V4	V4	NN	B-NP	B-protein
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
MV	MV	NN	B-NP	B-protein
O2	O2	NN	I-NP	I-protein
of	of	IN	B-PP	O
17.0	17.0	CD	B-NP	O
ml/min/kg	ml/min/kg	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
until	until	IN	B-PP	O
three	three	CD	B-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
lose	lose	VB	I-VP	O
weight	weight	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
approximately	approximately	RB	B-NP	O
35	35	CD	I-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
report	report	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
increasingly	increasingly	RB	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
occasional	occasional	JJ	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
greatly	greatly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
beginning	begin	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
indigestion	indigestion	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
intermittent	intermittent	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
watery	watery	NN	I-NP	O
brown	brown	NN	I-NP	O
stools	stool	NNS	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
without	without	IN	B-PP	O
hematochezia	hematochezia	NN	B-NP	O
,	,	,	I-NP	O
melena	melena	NN	I-NP	O
or	or	CC	I-NP	O
fevers	fever	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
workup	workup	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
Echo	Echo	NNP	I-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	B-protein
revealed	reveal	VBD	B-VP	I-protein
EF	EF	NN	B-NP	I-protein
at	at	IN	B-PP	O
24	24	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
decreased	decrease	VBN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
size	size	NN	I-NP	O
5.7	5.7	CD	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
with	with	IN	B-PP	O
peak	peak	NN	B-NP	O
RV	RV	NN	I-NP	O
pressure	pressure	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
58	58	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
ETT	ETT	NN	I-NP	O
on	on	IN	B-PP	O
5/25	5/25	CD	B-NP	O
was	be	VBD	B-VP	O
7	7	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
31	31	CD	B-NP	O
seconds	second	NNS	I-NP	O
in	in	IN	B-PP	O
duration	duration	NN	B-NP	O
.	.	.	O	O

MV	MV	NN	B-NP	B-protein
O2	O2	NN	I-NP	I-protein
of	of	IN	B-PP	O
15.9	15.9	CD	B-NP	O
with	with	IN	B-PP	O
peak	peak	JJ	B-NP	O
uptake	uptake	NN	I-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
threshold	threshold	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-PP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
and	and	CC	I-NP	O
tonsillectomy	tonsillectomy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Vasotec	Vasotec	NNP	B-NP	O
5	5	CD	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
:	:	:	O	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
.	.	.	O	O

HABITS	HABITS	NNS	B-NP	O
:	:	:	O	O
Occasional	Occasional	JJ	B-NP	O
ETOH	ETOH	NN	I-NP	O
on	on	IN	B-PP	O
weekends	weekend	NNS	B-NP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
three	three	CD	I-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
beers	beer	NNS	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
pack	pack	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
times	time	NNS	I-NP	O
ten	ten	CD	B-NP	O
years	year	NNS	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
reports	report	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
stopped	stop	VBN	I-VP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
marijuana	marijuana	NN	B-NP	O
use	use	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
stopped	stop	VBN	I-VP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
mother	mother	NN	I-NP	O
,	,	,	O	O
sister	sister	NN	B-NP	O
,	,	,	O	O
brother	brother	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
numerous	numerous	JJ	B-NP	O
other	other	JJ	I-NP	O
relatives	relative	NNS	I-NP	O
with	with	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
As	As	IN	B-ADVP	O
above	above	RB	I-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
thin	thin	JJ	I-NP	O
white	white	JJ	I-NP	O
male	male	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
108/80	108/80	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
89	89	CD	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
22	22	CD	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
99.3	99.3	CD	I-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Weight	Weight	RB	B-NP	O
70.5	70.5	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Benign	Benign	NNP	B-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
CVP	CVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
10	10	CD	B-NP	O
cm	cm	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
pulses	pulse	NNS	B-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-VP	O
without	without	IN	B-PP	O
bruit	bruit	NN	B-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
;	;	:	O	O
III/VI	III/VI	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
;	;	:	O	O
S3	S3	NN	B-NP	B-protein
and	and	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
present	present	JJ	B-ADJP	O
;	;	:	O	O
apical	apical	JJ	B-NP	O
end	end	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
inferolaterally	inferolaterally	RB	B-ADVP	O
displaced	displace	VBD	B-VP	O
and	and	CC	I-VP	O
enlarged	enlarge	VBD	I-VP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Palpable	Palpable	JJ	B-NP	O
pulsatile	pulsatile	JJ	I-NP	O
liver	liver	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
3	3	CD	B-NP	O
cm	cm	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
costal	costal	JJ	I-NP	O
margin	margin	NN	I-NP	O
,	,	,	O	O
nontender	nontender	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
nondistended	nondistended	JJ	B-ADJP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
splenomegaly	splenomegaly	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
dry	dry	JJ	I-ADJP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Tinea	Tinea	NN	B-NP	O
infection	infection	NN	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
and	and	CC	I-NP	O
groin	groin	NN	I-NP	O
.	.	.	O	O

NEUROLOGIC	NEUROLOGIC	NN	B-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBD	B-VP	O
time	time	NN	B-NP	O
three	three	CD	I-NP	O
.	.	.	O	O

Cranial	Cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
III-XII	III-XII	CD	B-NP	O
were	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Motor	Motor	NN	B-NP	O
strength	strength	NN	I-NP	O
was	be	VBD	B-VP	O
5/5	5/5	CD	B-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Toes	Toe	NNS	B-NP	O
are	be	VBP	B-VP	O
downgoing	downgoe	VBG	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
137	137	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
99	99	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
18	18	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
91	91	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
249	249	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	B-DNA
140	140	CD	I-NP	I-DNA
,	,	,	O	O
LDH	LDH	NN	B-NP	B-protein
228	228	CD	I-NP	I-protein
,	,	,	O	O
alk	alk	NN	B-NP	O
phos	pho	NNS	I-NP	O
48	48	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
1.2	1.2	CD	I-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.6	0.6	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
5.4	5.4	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
35.2	35.2	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
186	186	CD	B-NP	O
.	.	.	O	O

Albumin	Albumin	NNP	B-NP	O
3.2	3.2	CD	I-NP	O
,	,	,	O	O
uric	uric	JJ	B-NP	O
acid	acid	NN	I-NP	O
10.3	10.3	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
97	97	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
or	or	CC	O	O
Q	Q	NN	B-NP	O
waves	wave	NNS	I-NP	O
present	present	VBP	B-VP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
or	or	CC	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

Cardiomegaly	Cardiomegaly	NNP	B-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Enlarged	Enlarged	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
28	28	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
70/30	70/30	CD	I-NP	O
,	,	,	O	O
RV	RV	NN	B-NP	B-protein
70/8	70/8	CD	I-NP	I-protein
,	,	,	O	O
right	right	JJ	B-NP	O
atrium	atrium	NN	I-NP	O
12	12	CD	I-NP	O
,	,	,	O	O
mixed	mixed	JJ	B-NP	O
venous	venous	JJ	I-NP	O
saturation	saturation	NN	I-NP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
SVC	SVC	NN	B-NP	O
saturation	saturation	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Following	Follow	VBG	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Estevane	Estevane	NNP	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
tailored	tailor	VBN	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
nitroprusside	nitroprusside	NN	B-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Isordil	Isordil	NN	B-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
sodium	sodium	NN	B-NP	O
and	and	CC	I-NP	O
fluid	fluid	NN	I-NP	O
restricted	restrict	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
transplant	transplant	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
workup	workup	NN	I-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
serologies	serology	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
LFTs	LFT	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
borderline	borderline	JJ	I-NP	B-protein
hepatitis	hepatitis	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
.	.	.	O	O

LFTs	LFT	NNS	B-NP	B-protein
gradually	gradually	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
were	be	VBD	B-VP	O
likely	likely	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
passive	passive	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
alcohol	alcohol	NN	B-NP	O
use	use	NN	I-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
but	but	CC	O	O
less	less	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
following	follow	VBG	B-PP	O
nitroprusside	nitroprusside	NN	B-NP	O
therapy	therapy	NN	I-NP	O
overnight	overnight	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
SVR	SVR	NN	I-NP	B-protein
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
1000	1000	CD	B-NP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
of	of	IN	B-PP	O
4.71	4.71	CD	B-NP	O
,	,	,	O	O
CVP	CVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
9	9	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
as	as	IN	B-SBAR	O
further	further	RBR	B-ADJP	O
evidenced	evidence	VBN	I-ADJP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
and	and	CC	I-NP	O
Isordil	Isordil	NNP	I-NP	O
doses	dose	NNS	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
while	while	IN	B-SBAR	O
weaning	wean	VBG	B-VP	O
nitroprusside	nitroprusside	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
80	80	CD	B-NP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
and	and	CC	O	O
SVR	SVR	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1200	1200	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
GI	GI	NN	I-NP	O
complaints	complaint	NNS	I-NP	O
resolved	resolve	VBD	B-VP	O
immediately	immediately	RB	B-ADVP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Fannie	Fannie	NNP	B-NP	O
Rippel	Rippel	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
randomized	randomize	VBN	I-VP	O
to	to	TO	B-PP	O
hemodynamic	hemodynamic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
final	final	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
with	with	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
Nitroprusside	Nitroprusside	NN	I-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
1/16/97	1/16/97	CD	B-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
on	on	IN	B-PP	O
1/16/97	1/16/97	CD	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
10/15/97	10/15/97	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
light-headedness	light-headedness	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
begin	begin	VB	I-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADJP	O
productive	productive	JJ	I-ADJP	O
of	of	IN	B-PP	O
clear	clear	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
beginning	begin	VBG	B-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
four	four	CD	I-NP	O
beat	beat	NN	I-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
nonsustained	nonsustained	JJ	I-NP	O
V-tach	V-tach	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
well-tolerated	well-tolerated	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
ETT	ETT	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
completed	complete	VBD	B-VP	O
in	in	IN	B-PP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
40	40	CD	B-NP	O
seconds	second	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
leg	leg	NN	B-NP	O
fatigue	fatigue	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
max	max	NN	I-NP	O
heart	heart	NN	I-NP	O
of	of	IN	B-PP	O
132	132	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
changes	change	NNS	B-NP	O
on	on	IN	B-PP	O
exercise	exercise	NN	B-NP	O
.	.	.	O	O

Peak	Peak	NNP	B-NP	O
V.	V.	NNP	I-NP	O
O2	O2	NN	I-NP	O
of	of	IN	B-PP	O
14.3	14.3	CD	B-NP	O
and	and	CC	O	O
without	without	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
optimized	optimize	VBN	I-VP	O
with	with	IN	B-PP	O
final	final	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
Cough	Cough	NNP	I-NP	O
continued	continue	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
infiltrate	infiltrate	NN	B-NP	O
.	.	.	O	O

Sputum	Sputum	NNP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
symptom	symptom	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
post	post	VB	I-VP	O
nasal	nasal	JJ	B-NP	O
drip	drip	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
symptom	symptom	NN	I-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

As	As	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
transplant	transplant	NN	I-NP	O
workup	workup	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
optimally	optimally	RB	I-VP	O
visualized	visualize	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
contraction	contraction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
ETT	ETT	NN	I-NP	O
was	be	VBD	B-VP	O
as	as	RB	I-VP	O
mentioned	mention	VBN	I-VP	O
above	above	IN	B-PP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
LV	LV	NN	B-NP	O
dilatation	dilatation	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
LV	LV	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
dilatation	dilatation	NN	I-NP	O
with	with	IN	B-PP	O
mild-to-moderate	mild-to-moderate	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
TR	TR	NN	I-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
velocity	velocity	NN	I-NP	O
of	of	IN	B-PP	O
3.2	3.2	CD	B-NP	O
consistent	consistent	JJ	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mm	mm	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
SVC	SVC	NN	B-NP	O
of	of	IN	B-PP	O
3.35	3.35	CD	B-NP	O
,	,	,	O	O
67	67	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
2.78	2.78	CD	B-NP	O
,	,	,	O	O
67	67	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
FEV1/FVC	FEV1/FVC	NN	B-NP	O
of	of	IN	B-PP	O
83	83	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
FEF	FEF	NNP	B-NP	O
25-75	25-75	CD	I-NP	O
68	68	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
FVL	FVL	NN	B-NP	B-protein
CO	CO	NN	I-NP	I-protein
corrected	correct	VBD	B-VP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
as	as	IN	B-SBAR	O
predicted	predict	VBN	B-VP	O
.	.	.	O	O

Hepatitis	Hepatitis	NN	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

CMV	CMV	NN	B-NP	O
:	:	:	O	O
IgG	IgG	NN	B-NP	B-protein
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
IgM	IgM	NN	B-NP	B-protein
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

EBV	EBV	NN	B-NP	O
:	:	:	O	O
IgG	IgG	NN	B-NP	B-protein
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
IgM	IgM	NN	B-NP	B-protein
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Mumps	Mump	NNS	B-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
VZV	VZV	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

Toxoplasma	Toxoplasma	NN	B-NP	O
IgG	IgG	NN	I-NP	O
borderline	borderline	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
positive	positive	JJ	I-NP	O
;	;	:	O	O
IgM	IgM	NN	B-NP	B-protein
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

PPD	PPD	NN	B-NP	O
with	with	IN	B-PP	O
mumps	mump	NNS	B-NP	O
and	and	CC	O	O
Candida	Candida	NNP	B-NP	O
control	control	NN	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
9/20/97	9/20/97	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
8/16/97	8/16/97	CD	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

By	By	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
feeling	feel	VBG	I-VP	O
extremely	extremely	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
ambulating	ambulate	VBG	B-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
energy	energy	NN	B-NP	O
and	and	CC	I-NP	O
appetite	appetite	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pains	pain	NNS	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
9/20/97	9/20/97	CD	B-NP	O
,	,	,	O	O
ETT	ETT	NNP	B-NP	O
9/20/97	9/20/97	CD	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
9/20/97	9/20/97	CD	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
11/3/97	11/3/97	CD	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
4/28/97	4/28/97	CD	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Captopril	Captopril	NNP	B-NP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
;	;	:	O	O
Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
increased	increase	VBD	B-VP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Lotrimin	Lotrimin	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
cream	cream	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
gram	gram	NN	I-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
liter	liter	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
will	will	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
8/16/97	8/16/97	CD	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
PPD	PPD	NN	I-NP	B-protein
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
read	read	VBN	B-VP	O
by	by	IN	B-PP	O
myself	myself	PRP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Giallorenzo	Giallorenzo	NNP	I-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ANDERSON	ANDERSON	NNP	B-NP	O
E.	E.	NNP	I-NP	O
SERANDOS	SERANDOS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
MI144	MI144	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HERIBERTO	HERIBERTO	NNP	B-NP	O
TORRELL	TORRELL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GS0	GS0	NNP	I-NP	O
ZF909/0080	ZF909/0080	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
23317	23317	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

PFHFI62GVA	PFHFI62GVA	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/28/97	10/28/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/28/97	10/28/97	CD	B-NP	O

